Busca avançada
Ano de início
Entree
(Referência obtida automaticamente do Web of Science, por meio da informação sobre o financiamento pela FAPESP e o número do processo correspondente, incluída na publicação pelos autores.)

Organometallic gold(III) complexes with hybrid SNS-donating thiosemicarbazone ligands: cytotoxicity and anti-Trypanosoma cruzi activity

Texto completo
Autor(es):
Maia, P. I. da S. ; Carneiro, Z. A. ; Lopes, C. D. ; Oliveira, C. G. ; Silva, J. S. ; de Albuquerque, S. ; Hagenbach, A. ; Gust, R. ; Deflon, V. M. ; Abram, U.
Número total de Autores: 10
Tipo de documento: Artigo Científico
Fonte: DALTON TRANSACTIONS; v. 46, n. 8, p. 2559-2571, 2017.
Citações Web of Science: 12
Resumo

Stable organogold(III) compounds of the composition {[}Au-III(Hdamp)(L1)]Cl are formed from reactions of {[}AuCl2(damp)] with H(2)L1 (damp(-) = dimethylaminomethylphenyl; H(2)L1 = N'-(diethylcarbamothioyl)benz-imidothiosemicarbazides). The cationic complexes can be neutralized by reactions with weak bases under the formation of {[}Au-III(damp)(L1)] compounds. The structures of the products show interesting features like relatively short Au center dot center dot center dot H contacts between the methylene protons of the Hdamp ligand and the gold(III) ions. Preliminary biological studies on the uncoordinated compounds H(2)L1 and their gold complexes indicate considerable cytotoxicity for the {[}Au-III(Hdamp)(L1)]Cl complexes against MCF-7 cells. The in vitro trypanocidal activity was evaluated against the intracellular form of Trypanosoma cruzi. The organometallic complexes display a remarkable activity, which is dependent on the alkyl substituents of the thiosemicarbazone building blocks of the ligands. One representative of the cationic {[}Au-III(Hdamp)(L1)]Cl complexes, where H(2)L1 contains a dimethylthiosemicarbazide building block, shows a trypanocidal activity against the intracellular amastigote form in the same order of magnitude as that of the standard drug benznidazole. Furthermore, no appreciable toxicity to mice spleen cells is observed for this compound resulting in a therapeutic index of about 30, which strongly recommends it as a promising candidate for the development of a future antiparasitic drug. (AU)

Processo FAPESP: 09/54011-8 - EMU: aquisição de difratômetro de raios X de monocristal para análise estrutural de moléculas pequenas e proteínas
Beneficiário:Victor Marcelo Deflon
Linha de fomento: Auxílio à Pesquisa - Programa Equipamentos Multiusuários
Processo FAPESP: 11/16380-1 - Complexos de Au, Re e Tc com tiossemicarbazonas de interesse no desenvolvimento de fármacos ou radiofármacos para diagnóstico ou terapia
Beneficiário:Pedro Ivo da Silva Maia
Linha de fomento: Bolsas no Brasil - Pós-Doutorado